Clearmind Medicine (CMND) Net Income (2022 - 2026)
Clearmind Medicine (CMND) posted quarterly Net Income of $2.0 million for Q2 2026, up 161.2% year-over-year from $783928.0 in Q2 2025, and down 46.88% quarter-over-quarter from $3.9 million in Q1 2026.
Clearmind Medicine (CMND) Net Income (2022 - 2026) Analysis & Trends
Clearmind Medicine's Net Income history runs 5 years deep, the most recent figure standing at $2.0 million for Q2 2026.
- In Q2 2026, Net Income rose 161.2% year-over-year to $2.0 million; the TTM figure through Apr 2026 stood at $6.3 million (up 197.45% YoY), while the FY2025 annual figure was -$3.9 million, up 30.27% from the prior year.
- Net Income for Q2 2026 stood at $2.0 million, down from $3.9 million in the prior quarter.
- The five-year high for Net Income was $3.9 million in Q1 2026, with the low at -$5329.6 billion in Q3 2022.
- The 5-year median for Net Income is $908217.0 (2024), against an average of -$313.5 billion.
- The sharpest annual moves came in 2024 and 2025: Net Income jumped 264.04% in 2024, then plunged 37.27% in 2025.
- Clearmind Medicine's Net Income stood at -$5329.6 billion in 2022, then jumped by 100.0% to -$4.1 million in 2023, then surged by 55.49% to -$1.8 million in 2024, then jumped by 50.95% to -$894789.0 in 2025, then surged by 328.84% to $2.0 million in 2026.
- Business Quant data shows CMND's Net Income at $2.0 million in Q2 2026, $3.9 million in Q1 2026, and -$894789.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.81 Bn | 130.96 Bn | 2.84 Bn | 1.10 Bn |
| 2 | Regeneron Pharmaceuticals | 86.07 Bn | 78.08 Bn | 3.93 Bn | 1.30 Bn |
| 3 | Argenx Se | 65.47 Bn | 60.29 Bn | 1.37 Bn | 482.00 Mn |
| 4 | Moderna | 55.64 Bn | 50.50 Bn | 52.00 Mn | -782.00 Mn |
| 5 | BeOne Medicines | 41.99 Bn | 36.89 Bn | 1.53 Bn | 237.01 Mn |
| 6 | Alnylam Pharmaceuticals | 31.68 Bn | 28.37 Bn | 992.69 Mn | 164.49 Mn |
| 7 | BioNTech SE | 27.69 Bn | 9.29 Bn | 668.28 Mn | -355.03 Mn |
| 8 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -13.27 Mn |
| 9 | Royalty Pharma | 27.36 Bn | 26.52 Bn | - | 81.49 Mn |
| 10 | Clearmind Medicine | 531,486.84 | -13.06 Mn | - | 2.05 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 2.05 Mn |
| Jan 31, 2026 | 3.85 Mn |
| Oct 31, 2025 | -894,789.00 |
| Jul 31, 2025 | 1.31 Mn |
| Apr 30, 2025 | 783,928.00 |
| Jan 31, 2025 | 1.07 Mn |
| Oct 31, 2024 | -1.82 Mn |
| Jul 31, 2024 | 2.09 Mn |
| Apr 30, 2024 | 908,217.00 |
| Jan 31, 2024 | 1.37 Mn |
| Oct 31, 2023 | -4.10 Mn |
| Jul 31, 2023 | 575,187.00 |
| Apr 30, 2023 | -1.52 Mn |
| Jan 31, 2023 | 1.90 Mn |
| Jul 31, 2022 | -5,329.57 Bn |
| Apr 30, 2022 | -1.84 Mn |
| Jan 31, 2022 | 1.65 Mn |